Intellia Therapeutics, Inc. (NTLA)
12.76
-0.09
(-0.70%)
USD |
NASDAQ |
Mar 13, 16:00
12.79
+0.03
(+0.24%)
After-Hours: 20:00
Intellia Therapeutics Shareholders Equity (Quarterly) : 671.39M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 1.238B |
| Recursion Pharmaceuticals, Inc. | 1.131B |
| Personalis, Inc. | 261.18M |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Pacific Biosciences of California, Inc. | 5.349M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 842.13M |
| Total Liabilities (Quarterly) | 170.73M |
| Debt to Equity Ratio | 0.139 |
| Current Ratio | 5.080 |
| Net Debt Paydown Yield | 0.16% |